全文获取类型
收费全文 | 12946篇 |
免费 | 868篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 138篇 |
儿科学 | 390篇 |
妇产科学 | 163篇 |
基础医学 | 2131篇 |
口腔科学 | 333篇 |
临床医学 | 1060篇 |
内科学 | 2699篇 |
皮肤病学 | 459篇 |
神经病学 | 1391篇 |
特种医学 | 688篇 |
外国民族医学 | 2篇 |
外科学 | 1586篇 |
综合类 | 88篇 |
一般理论 | 2篇 |
预防医学 | 899篇 |
眼科学 | 222篇 |
药学 | 777篇 |
中国医学 | 16篇 |
肿瘤学 | 804篇 |
出版年
2023年 | 69篇 |
2022年 | 92篇 |
2021年 | 240篇 |
2020年 | 169篇 |
2019年 | 214篇 |
2018年 | 256篇 |
2017年 | 198篇 |
2016年 | 276篇 |
2015年 | 334篇 |
2014年 | 383篇 |
2013年 | 510篇 |
2012年 | 790篇 |
2011年 | 828篇 |
2010年 | 446篇 |
2009年 | 452篇 |
2008年 | 725篇 |
2007年 | 734篇 |
2006年 | 708篇 |
2005年 | 664篇 |
2004年 | 605篇 |
2003年 | 633篇 |
2002年 | 584篇 |
2001年 | 283篇 |
2000年 | 308篇 |
1999年 | 281篇 |
1998年 | 160篇 |
1997年 | 131篇 |
1996年 | 103篇 |
1995年 | 93篇 |
1994年 | 79篇 |
1993年 | 79篇 |
1992年 | 125篇 |
1991年 | 123篇 |
1990年 | 118篇 |
1989年 | 121篇 |
1988年 | 134篇 |
1987年 | 148篇 |
1986年 | 128篇 |
1985年 | 120篇 |
1984年 | 92篇 |
1983年 | 72篇 |
1981年 | 51篇 |
1979年 | 77篇 |
1978年 | 65篇 |
1974年 | 64篇 |
1973年 | 75篇 |
1972年 | 54篇 |
1971年 | 52篇 |
1970年 | 49篇 |
1968年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
2.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
3.
Baher Husain Christian Kuehne Christian Waydhas Ulrike Lewan Claudia Ose Dieter Nast-Kolb Steffen Ruchholtz 《European Journal of Trauma》2006,32(6):548-554
Abstract
Background: Does there exist a difference in the outcome of severely injured children and severely injured healthy adults?
Methods: The data of 1,566 severely injured patients, treated between May 1998 and December 2002 in our emergency department of the
University Essen/Germany, were analyzed. Patients with an injury severity score (ISS) > 24 were included in the present study.
Patients younger as 18 (17) years were located to the children group c. Patients aged 18 and up to the age of 54 were included
in the adult group a.
Results: Fifty-four children and 252 adults met the selection criteria. ISS and the Glasgow coma scale (GCS) before intubation were
not statistically different in both groups. Seriously injured children stayed significantly shorter on the intensive care
unit, required significantly less ventilator days. Furthermore, the incidence of single organ failure (SOF) and multiple organ
failure (MOF) was significantly lower in the children group. Mortality in the children group (29.6%) was lower than that in
the adult group (33.7%). There was no death due to MOF in the children group as compared to 2.4% (n = 6) in the adults.
Conclusion: The incidence of SOF and MOF was significantly lower in the children group although there was no difference in ISS, GCS and
injury patterns. The prognosis of severely injured children was found to be better than those of adults. Moreover, there was
no death due to MOF in the children group. 相似文献
4.
Oil-emulsified (OE) and aqueous (Aq) vaccines were prepared with the same batch of inactivated A24 8345 foot and mouth disease virus (FMDV). Calves born to vaccinated dams did not respond to the Aq vaccine 30 or 90 days post partum. When the OE vaccine was used on a similar group of calves, no responses were elicited up to 21 days post partum. However, calves 30 or more days old responded like adult cattle to the OE vaccine. When the OE vaccine was used in colostral antibody-free calves 3-30 days old, all animals showed good antibody responses but, in calves vaccinated 3 or 7 days post partum, antibodies were detectable only after a considerable period of time. Our results show that both passively acquired colostral antibodies and age are important in the response of very young calves to FMDV oil vaccines. From a practical point of view, in endemic areas where adult cattle are periodically vaccinated, vaccination of calves between 30 and 60 days post partum with OE vaccines would lead to high levels of herd protection. 相似文献
5.
The Resource-Based Relative Value Scale. Toward the development of an alternative physician payment system 总被引:2,自引:0,他引:2
This article describes the design and methods of a study currently under way to develop a Resource-Based Relative Value Scale (RBRVS); an alternative basis for establishing the payment rate for the services and procedures (S/Ps) of physicians in medical and surgical specialties. Physician resource inputs to be measured include (1) S/P time, (2) pre-S/P and post-S/P times, (3) intensity, (4) practice costs, including malpractice premiums, and (5) the cost of specialty training. These five factors will be combined to produce an RBRVS denominated in nonmonetary units. In the initial phase of the study, data on time and intensity will be obtained through a national survey of physicians who perform these S/Ps. In the second, consensus phase of the project, the investigators will convene a panel of representatives of the medical profession, third-party payers, consumers, and other interested parties to examine areas of agreement and disagreement as to how an RBRVS should be used for policy purposes. The final results of this study are expected by the summer of 1988. 相似文献
6.
7.
Kinzl Geelen F. Ferrio Langsteiner Dubitscher Pfister H. Donalies Kranz G. A. Adam Koller v. Baeyer Zillig G. Rost Sjvall Einar Hahn Rubner Max H. Hofmann Bresowsky Mller H. Liguori-Hohenauer Geller Braun F. Leibbrand Tbben H. 《International journal of legal medicine》1940,33(4):353-364
International Journal of Legal Medicine - 相似文献
8.
Sabrina Hundt Ulrike Haug Hermann Brenner 《Cancer epidemiology, biomarkers & prevention》2007,16(10):1935-1953
BACKGROUND: Despite different available methods for colorectal cancer (CRC) screening and their proven benefits, morbidity, and mortality of this malignancy are still high, partly due to low compliance with screening. Minimally invasive tests based on the analysis of blood specimens may overcome this problem. The purpose of this review was to give an overview of published studies on blood markers aimed at the early detection of CRC and to summarize their performance characteristics. METHOD: The PUBMED database was searched for relevant studies published until June 2006. Only studies with more than 20 cases and more than 20 controls were included. Information on the markers under study, on the underlying study populations, and on performance characteristics was extracted. Special attention was given to performance characteristics by tumor stage. RESULTS: Overall, 93 studies evaluating 70 different markers were included. Most studies were done on protein markers, but DNA markers and RNA markers were also investigated. Performance characteristics varied widely between different markers, but also between different studies using the same marker. Promising results were reported for some novel assays, e.g., assays based on SELDI-TOF MS or MALDI-TOF MS, for some proteins (e.g., soluble CD26 and bone sialoprotein) and also for some genetic assays (e.g., L6 mRNA), but evidence thus far is restricted to single studies with limited sample size and without further external validation. CONCLUSIONS: Larger prospective studies using study populations representing a screening population are needed to verify promising results. In addition, future studies should pay increased attention to the potential of detecting precursor lesions. 相似文献
9.
10.
Long-term complications of renal transplantation 总被引:3,自引:0,他引:3
W E Braun 《Kidney international》1990,37(5):1363-1378